Navigation Links
Senators Cochran (R-MS), Boxer (D-CA), Brownback (R-KS) and Vitter (R-LA) Add Their Support to Lung Cancer Mortality Reduction Act
Date:9/25/2008

LCA Commends Additional Senate Co-sponsors

WASHINGTON, Sept. 25 /PRNewswire-USNewswire/ -- Today, Lung Cancer Alliance (LCA) commended the support of Senators Barbara Boxer (D-CA), Sam Brownback (R-KS), Thad Cochran (R-MS) and David Vitter (R-LA) as cosponsors of S.3187: The Lung Cancer Mortality Reduction Act.

The bill, introduced by Senators Feinstein (D-CA) and Hagel (R-NE), requires the Secretaries of Health and Human Services, Defense and Veterans Affairs to combine forces on a comprehensive, coordinated plan of action to reduce lung cancer mortality by 50% by 2015.

"My home state of Mississippi has one of the nation's highest lung cancer mortality rates, so I understand the devastating impact this disease can have," said Senator Thad Cochran (R-MS) who is the highest ranking Republican member of the Senate Appropriations Committee. "I am pleased this legislation includes provisions that will authorize increased funding for lung cancer research and stimulate cooperation among relevant federal agencies."

The bill would establish in law the first ever multi-agency, comprehensive program targeted at lung cancer, and would authorize funding for a five year program to reduce the mortality rate of lung cancer, which causes more deaths each year than all other major cancers combined.

Lung cancer takes the lives of three times as many men as prostate cancer and nearly twice the number of women as breast cancer. In fact, more women are dying each year from lung cancer than breast, ovarian, cervical and uterine cancers combined.

"It is critical that we prioritize lung cancer by expanding lung cancer research initiatives and increasing access to life-saving treatments for patients," said Senator Sam Brownback (R-KS), who is co-chair of the Senate Cancer Caucus and co-author of the Senate resolution last year that laid the groundwork for S.3187.

All agencies of HHS, including the National Cancer Institute, Centers
'/>"/>

SOURCE Lung Cancer Alliance
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. House Passes Historic Bill to Protect Kids from Tobacco; Senators Bond & McCaskill Should Cosponsor Legislation
2. House Passes Historic Bill to Protect Kids from Tobacco; Senators Bennett & Hatch Should Cosponsor Legislation
3. House Passes Historic Bill to Protect Kids From Tobacco; Senators Webb & Warner Should Cosponsor Legislation
4. Senators Chuck Hagel and Dianne Feinstein Make Lung Cancer Matter
5. National Patient Advocate Foundation Applauds Senators Lautenberg and Brown for Protecting Health Care Coverage for At-Risk Children
6. AARP Protests Medicare Premium Increases, Delivering Over 20,000 Petitions to Senators Hutchison and Cornyn
7. AGD Thanks Senators for Introducing Bill to Reauthorize the Dental Health Improvement Act
8. AGD Applauds Sen. Cardin Oral Health Initiative Bill; Urges All Senators to Co-Sponsor Measure
9. Bipartisan Group of Senators and Representatives Introduce Bill to Battle Brain-Related Illness
10. Video: Senators and CEOs Urge Passage of Health IT Bill Now
11. Home Oxygen Community Applauds Senators Olympia Snowe and Susan Collins for Joining Bi-Partisan Effort to Formally Oppose Proposed Cuts to Medicares Home Oxygen Benefit

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2009)...ariation believed to affect circadian rhythm, ,... New research suggests that an internal body clock...evelopment of bipolar disorder in children. , ...netic makeup of 152 children with bipolar disorder...swings, and 140 children without the disorder. The...
(Date:11/27/2009)...RD, Mass., Nov. 27 GSI G...upplier of precision technology products and semic...eeting of the Company,s shareholders has been sche...cation of the meeting will be announced in due cou...d a requisition notice from Stephen Bershad, a hol...
(Date:11/27/2009)... Biotech firm Replikins Ltd. today issued i...enomic data. It shows that the lethality of the v...uring the virus,s current outbreak in the spring o... 2.0 (s.d. 0.1). The H1N1 infectivity count, howev...Boston (PRWEB) November 27, 2009 -- Biotech firm R...
(Date:11/27/2009)...NCISCO, Nov. 27 The Gymb...lair Lambert, CFO/COO, will present at the NASDAQ ...he May Fair Hotel in London, England, on Wednesday...sten to a live broadcast of The Gymboree Corporati... to www.gymboree.com, click on "Our Company" at th...
(Date:11/27/2009)...LLY-SUR-SEINE, France, Nov. 27 Tea...al cycling team dedicated to ethical sporting and ...s, announced today that it will become Team Garmin...cal as a new sponsor of the team. Transitions Opti...e eyewear, offering the most advanced photochromic...
Breaking Medicine News(10 mins):Health News:Bipolar Disorder May Be Tied to Body Clock 2Health News:GSI Group Calls Shareholders Meeting 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3
...s health plans in member satisfaction in four key ... Kaiser Permanente announced today that its member...n,s health plans highest in customer satisfaction ...west. These plans serve almost 7.5 million of Kai...
... include improved patient outcomes and , real-time... Somanetics Corporation (Nasdaq: SMTS ) announc... and Drug Administration (FDA) to expand the label...sed to manage therapies in patients above 2.5 kilo...
...l 16 Vion Pharmaceuticals, Inc. (OTC Bulletin Bo...ication (NDA) for its lead oncology therapeutic On...r review by the U.S. Food and Drug Administration ...gent for remission induction treatment for patient...
...Will Earn Decision Resources, Clinical Gold Standa...g to a New Report from Decision Resources , , WAL...the world,s leading research and advisory firms fo... that most influences their prescribing decisions ...
...and Vitamins Play an Important Role in Preventing ...rriors take note: Bursts of high-energy athletic a...lined by injury from overexertion. Overall wellnes...dy shows 91 percent of orthopedic specialists woul...
...d HIV business with the independence and sustainab...ment, access and shareholder value , - Renews focu... more new HIV treatments , - Equity split of 85% G...e entered into an agreement to create a new world-...
Other Medicine News:Health News:Kaiser Permanente Receives Top Marks in 2009 J.D. Power and Associates Study 2Health News:Kaiser Permanente Receives Top Marks in 2009 J.D. Power and Associates Study 3Health News:Kaiser Permanente Receives Top Marks in 2009 J.D. Power and Associates Study 4Health News:Somanetics Announces New FDA 510(K) Clearance 2Health News:Somanetics Announces New FDA 510(K) Clearance 3Health News:Vion Pharmaceuticals' New Drug Application for Onrigin(TM)Accepted For Review by the FDA 2Health News:Vion Pharmaceuticals' New Drug Application for Onrigin(TM)Accepted For Review by the FDA 3Health News:For Ulcerative Colitis, Surveyed Experts Indicate That Corticosteroids Have Advantages Over Remicade in the Induction of Remission 2Health News:For Ulcerative Colitis, Surveyed Experts Indicate That Corticosteroids Have Advantages Over Remicade in the Induction of Remission 3Health News:Video: Helping Weekend Warriors Stay in the Game 2Health News:Video: Helping Weekend Warriors Stay in the Game 3Health News:GlaxoSmithKline and Pfizer Announce Innovative Agreement to Create a New World-Leading, Specialist HIV Company 2Health News:GlaxoSmithKline and Pfizer Announce Innovative Agreement to Create a New World-Leading, Specialist HIV Company 3Health News:GlaxoSmithKline and Pfizer Announce Innovative Agreement to Create a New World-Leading, Specialist HIV Company 4Health News:GlaxoSmithKline and Pfizer Announce Innovative Agreement to Create a New World-Leading, Specialist HIV Company 5Health News:GlaxoSmithKline and Pfizer Announce Innovative Agreement to Create a New World-Leading, Specialist HIV Company 6Health News:GlaxoSmithKline and Pfizer Announce Innovative Agreement to Create a New World-Leading, Specialist HIV Company 7Health News:GlaxoSmithKline and Pfizer Announce Innovative Agreement to Create a New World-Leading, Specialist HIV Company 8Health News:GlaxoSmithKline and Pfizer Announce Innovative Agreement to Create a New World-Leading, Specialist HIV Company 9
(Date:11/25/2009)..., PRINCETON, N.J., Nov. 25 /PRNewswire-FirstCall/...stage pharmaceutical company committed to discover... treat viral infections, reported financial result... September 30, 2009 Pharmasset held $58.4 million ...ts. ,, Pipeline Update and 2009 Highlights ,...
(Date:11/25/2009)..., CHICAGO and STAFA, Switzerland, Nov. 25 /PRNewsw...manufacturer of innovative hearing solutions, pres...dults Conference, focusing on the special needs of...ther leading experts in aging and audiology from a...ork everyday with older people with hearing loss f...
(Date:11/25/2009)... BRIDGEWATER, N.J., Nov. 25 The FD... (etravirine) tablets, a non-nucleoside reverse tr...ly NNRTI specifically indicated for use in treatme...ic failure with HIV-1 strains resistant to an NNRT...itional approval is based on 48-week data from two...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5Soy in the Diet May Protect Lung Function 50201 1The Psychology of Celebrity Worship 50198 1The Psychology of Celebrity Worship 50198 2The Psychology of Celebrity Worship 50198 3CareFusion Names Robert Friel to Board of Directors 50196 1CareFusion Names Robert Friel to Board of Directors 50196 2CareFusion Names Robert Friel to Board of Directors 50196 3
...ta from two Phase 3 trials show clinical success r...ibiotic therapy, WELLESLEY HILLS, Mass., March 13... announced today the presentation of,a poster enti...y for,Treating Infected Diabetic Foot Ulcers: A Ra...rial of Pexiganan Cream." The poster will be,prese...
...S, March 12 Eli Lilly and Company,(NYSE: LLY ), ...mpany,practices as alleged by the Connecticut Atto...issued March 11, 2008., The tone and content of t...rently be taking Zyprexa to treat a life-threateni...ed no acknowledgement of the,seriousness of schizo...
Other Medicine Technology:MacroChem Announces Presentation of Pexiganan Phase 3 Study Results for Topical Treatment of Diabetic Foot Infection 2MacroChem Announces Presentation of Pexiganan Phase 3 Study Results for Topical Treatment of Diabetic Foot Infection 3MacroChem Announces Presentation of Pexiganan Phase 3 Study Results for Topical Treatment of Diabetic Foot Infection 4MacroChem Announces Presentation of Pexiganan Phase 3 Study Results for Topical Treatment of Diabetic Foot Infection 5Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release 2Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release 3Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release 4
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
Medicine Products: